Logo

American Heart Association

  42
  0


Final ID:

Where Do We Go Next: New Treatment Targets for PAH

  • Vachiery, Jean-luc  ( H.U.B. Erasme University Hospital , Brussels , Belgium )
  • Weatherald, Jason  ( University of Alberta , Edmonton , Alberta , Canada )
  • Frantz, Robert  ( MAYO CLINIC , Rochester , Minnesota , United States )
  • Humbert, Marc  ( Universite Paris-Saclay , Le Kremlin-Bicetre , France )
  • Author Disclosures:
    Jean-Luc Vachiery: DO have relevant financial relationships ; Consultant:Tectonic:Active (exists now) ; Consultant:Pulnovo:Active (exists now) ; Consultant:Inhibikase:Active (exists now) ; Consultant:Pulmovant:Active (exists now) ; Consultant:Merck/MSD:Active (exists now) ; Consultant:Insmed:Active (exists now) ; Consultant:GossamerBio:Active (exists now) ; Consultant:Johnson & Johnson:Past (completed) | Jason Weatherald: DO have relevant financial relationships ; Consultant:Merck:Past (completed) ; Speaker:United Therapeutics:Past (completed) ; Advisor:Apollo Therapeutics:Past (completed) ; Research Funding (PI or named investigator):United Therapeutics:Active (exists now) ; Research Funding (PI or named investigator):Merck:Active (exists now) ; Speaker:Janssen:Past (completed) ; Speaker:Janssen:Expected (by end of conference) | Robert Frantz: No Answer | Marc Humbert: DO have relevant financial relationships ; Consultant:Merck:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Recent Advances in PAH

Sunday, 11/09/2025 , 03:30PM - 04:45PM

Cardiovascular Seminar

More abstracts on this topic:
More abstracts from these authors:
My Patient Has PAH: How Do I Risk Stratify?

Benza Raymond, Frantz Robert, Weatherald Jason

Round Table

Vachiery Jean-luc

You have to be authorized to contact abstract author. Please, Login
Not Available